WA
WestEnd Advisors Portfolio holdings
AUM
$4.03B
This Quarter Return
+1.86%
1 Year Return
+16.84%
3 Year Return
+52.53%
5 Year Return
+81.57%
10 Year Return
+163.89%
AUM
$3.87B
AUM Growth
+$3.87B
(+0.24%)
Cap. Flow
-$4.42M
Cap. Flow
% of AUM
-0.11%
Top 10 Holdings %
Top 10 Hldgs %
66.62%
Holding
372
New
17
Increased
69
Reduced
105
Closed
6
Top Buys
| 1 |
iShares US Broker-Dealers & Securities Exchanges ETF
IAI
|
$91.8M |
| 2 |
Goldman Sachs
GS
|
$40.3M |
| 3 |
Financial Select Sector SPDR Fund
XLF
|
$38M |
| 4 |
Technology Select Sector SPDR Fund
XLK
|
$7.38M |
| 5 |
Apple
AAPL
|
$7.24M |
Top Sells
| 1 |
Health Care Select Sector SPDR Fund
XLV
|
$119M |
| 2 |
Johnson & Johnson
JNJ
|
$30.4M |
| 3 |
NVIDIA
NVDA
|
$21.3M |
| 4 |
Vanguard FTSE All-World ex-US ETF
VEU
|
$14.5M |
| 5 |
Amazon
AMZN
|
$11.7M |
Sector Composition
| 1 | Technology | 5.21% |
| 2 | Healthcare | 4.04% |
| 3 | Financials | 3.05% |
| 4 | Consumer Discretionary | 3.02% |
| 5 | Communication Services | 2.8% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
101
Boston Scientific
BSX
$159B
| $1.39K | ﹤0.01% |
18
-5
| -22% | -$385 |
|
102
Intercontinental Exchange
ICE
$100B
| $1.37K | ﹤0.01% |
10
+8
| +400% | +$1.1K |
|
103
Stryker
SYK
$149B
| $1.36K | ﹤0.01% |
4
-1
| -20% | -$340 |
|
104
Cigna
CI
$80.2B
| $1.32K | ﹤0.01% |
4
-1
| -20% | -$331 |
|
105
Philip Morris
PM
$254B
| $1.32K | ﹤0.01% |
13
| – | – |
|
106
Advanced Micro Devices
AMD
$263B
| $1.3K | ﹤0.01% |
8
-1
| -11% | -$162 |
|
107
McDonald's
MCD
$226B
| $1.27K | ﹤0.01% |
5
| – | – |
|
108
KKR & Co
KKR
$120B
| $1.26K | ﹤0.01% |
+12
| New | +$1.26K |
|
109
Moody's
MCO
$89B
| $1.26K | ﹤0.01% |
3
+2
| +200% | +$842 |
|
110
Southern Company
SO
$101B
| $1.24K | ﹤0.01% |
16
-1
| -6% | -$78 |
|
111
CME Group
CME
$97.1B
| $1.18K | ﹤0.01% |
6
+5
| +500% | +$983 |
|
112
McKesson
MCK
$85.9B
| $1.17K | ﹤0.01% |
2
| – | – |
|
113
Oracle
ORCL
$628B
| $1.13K | ﹤0.01% |
8
-1
| -11% | -$141 |
|
114
Wells Fargo
WFC
$258B
| $1.13K | ﹤0.01% |
19
+5
| +36% | +$297 |
|
115
Adobe
ADBE
$148B
| $1.11K | ﹤0.01% |
2
-1
| -33% | -$556 |
|
116
Gilead Sciences
GILD
$140B
| $1.1K | ﹤0.01% |
16
-4
| -20% | -$275 |
|
117
Lam Research
LRCX
$124B
| $1.07K | ﹤0.01% |
1
| – | – |
|
118
Regeneron Pharmaceuticals
REGN
$59.8B
| $1.05K | ﹤0.01% |
1
-1
| -50% | -$1.05K |
|
119
Cisco
CSCO
$268B
| $1.05K | ﹤0.01% |
22
-1
| -4% | -$48 |
|
120
Zoetis
ZTS
$67.6B
| $1.04K | ﹤0.01% |
6
-1
| -14% | -$173 |
|
121
Bristol-Myers Squibb
BMY
$96.7B
| $1.04K | ﹤0.01% |
25
-8
| -24% | -$332 |
|
122
Constellation Energy
CEG
$96.4B
| $1K | ﹤0.01% |
5
| – | – |
|
123
Texas Instruments
TXN
$178B
| $973 | ﹤0.01% |
5
| – | – |
|
124
CVS Health
CVS
$93B
| $945 | ﹤0.01% |
16
-4
| -20% | -$236 |
|
125
Applied Materials
AMAT
$124B
| $944 | ﹤0.01% |
4
-1
| -20% | -$236 |
|